drugset / Trial / NCT02133404
A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To examine efficacy and safety after 12-week administration of ASP7991 in secondary hyperparathyroidism patients undergoing hemodialysis
Timeline
- Start
- 2014-03-14
- Primary completion
- 2014-11-10
- Completion
- 2014-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASP7991 | Unknown | — | Oral |
| Comparator | Cinacalcet | Other / unclassified | — | Oral |